Each ml contains
Xylazine 100 mg
Xylazine is an a2-adrenergic drug with sedative, analgesic and muscle relaxing properties which acts via the CNS. Xylazine is thought to act by activation of the central presynaptic a2-receptors. Activation of these central a2-receptors seems to regulate central dopamine and norepinephrine storage or release. Xylazine’s analgesic and sedative actions are related to its central nervous system depression, while the muscle relaxant effects are due to the inhibition of the intraneural transmission of impulses in the central nervous system.
Xylazine is a sedative with analgesic and muscle relaxant properties.
The product is for use in horses only, in cases where sedation is required including:
Horses
by slow intravenous injection
Horses : 0.5-1 mg per kg body weight
Horses : 0.5-1 ml per 100 kg body weight
Should be used with caution when pulmonary disease is suspected.
Side effects of bradycardia, cardiac arrhythmia and polyuria may occur.
Following intravenous administration a transient rise followed by a fall in blood pressure usually occurs
None
Store in dry dark and place at temperature not exceeding to 30 o.
Vial of 50,100 and 250 ml